A total of 91 non-typhoid Salmonella isolated from pediatric patients with diarrhea in Seoul from 2003 to 2009 was tested for antimicrobial susceptibility of nalidixic acid (NA). Forty strains of NA resistance or intermediate susceptible non-typhoid Salmonella were identified and their minimum inhibitory concentrations (MICs) of NA, ciprofloxacin (CIP), and norfloxacin (NOR) were determined. Of the 40 isolates, 26 were resistant to NA (MIC >256 μg/ml). Only one isolate was high-level resistant to CIP (12 μg/ml) and NOR (48 μg/ml). Mutations in gyrA and parC genes were studied by PCR and sequencing. All NA-resistant isolates carried point mutations in the gyrA quinolone resistance determining regions (QRDR) at codon 83 or 87 (MICs of NA, >256 μg/ml; MICs of CIP, 0.047~0.25 μg/ml; MICs of NOR, 0.38~1.5 μg/ml). A double change in GyrA was found in one Salmonella Enteritidis (MIC of CIP, 12 μg/ml; MIC of NOR, 48 μg/ml). In respect of the ParC protein, a single change at Thr57→Ser was found in 3 isolates (MICs of NA, >256 μg/ml; MICs of CIP, 0.19~0.25 μg/ml; MICs of NOR, 1 μg/ml). At the same time, these strains changed from Ser83 to Tyr in the gyrA. The result of the investigation for the prevalence of plasmid-mediated quinolone resistance (PMQR) genes, 14 isolates harbored qnr gene among 40 isolates. All of 14 isolates showed decreased susceptibility at NA (MICs 4~16 μg/ml) and except one strain, all of qnr genes were identified as qnrB. Mutations in the gyrA gene and production of PMQR determinants were critical for quinolone resistance and decreased susceptibility to fluoroquinolone in these isolates.
INTRODUCTION
Salmonella enterica is widespread in humans and animals worldwide and is of increasing public health concern as causative pathogens of food poisoning (1) . While approximately 2000 serotypes of Salmonella have been associated with enterocolitis, Salmonella Typhimurium and Salmonella Enteritidis are two major etiologic agents of food-borne salmonellosis in human (2) . Non-typhoidal salmonellosis in humans is usually a self-limiting disease confined to the gastrointestinal tract, therefore antibiotic treatment is not recommended. However, antibiotic therapy may be required in immunocopromised patients, in cases of extraintestinal infections, and for infants and elderly peoples (3) . In the treatment of the non-typhoid Salmonella, the ciprofloxacin is used and recently it is the tendency that the resistance is gradually increased to the all, globally, the quinolone antibiotic (4, 5) . In 2011, according to Korea Center for Disease The first quinolone, NA, was introduced into clinical use at the beginning of the 1960s (6) . In the 1980s, ciprofloxacin (CIP), a fluoroquinolone with a wide spectrum of in vitro antibacterial activity, particularly against gram negative bacteria, first became clinically available (7). However, this high level of use, and to some degree of misuse in the sense of unnecessary use, or use of quinolones with poor activity in some developing countries, has been blamed for the rapid development of bacterial resistance to these agents (4).
Quinolone resistance in Gram-negative bacteria is primarily attributable to mutations in the quinolone resistance determining regions (QRDR) consisting of the gyrA and parC genes, which are the subunits of the target enzymes of quinolones, DNA gyrase subunit A and topoisomerase IV, respectively (8) . Other mechanisms of resistance, such as efflux pump systems or modifications of porins, can decrease susceptibility to quinolone (9) . In addition, decreased susceptibility to quinolones can be mediated by plasmid-mediated quinolone resistance genes, named qnr, aac(6')-Ib-cr and qepA (7) .
Research on the mechanisms of resistance to quinolones of Salmonella at the early 2000's was reported by several authors in Korea, but there are few reports on the latest strains. In the present study, we investigated the mutations in the QRDR and the prevalence of PMQR determinants of NA resistance or intermediate Salmonella isolated from pediatric patients with diarrhea in order to figure out their distribution and significance. 
MATERIALS AND METHODS

Isolation and identification of Salmonella
Detection of the quinolone resistance (PMQR) gene containing plasmids
All of the isolates showing resistance and intermediate susceptibility to NA were tested for the presence of PMQR genes (qnrA, qnrB, qnrS, aac(6')-Ib-cr, and qepA) by PCR using the primers listed in Table 1 (11~13) . Salmonella Enteritidis, accounting for 37.5% (15 isolates) followed by Montevideo (27.5%, 11 isolates), Hillingon (12.5%, 5 isolates), and Typhimurium (7.5%, 3 isolates).
RESULTS
Isolation and identification of Salmonella
The remaining 6 isolates belonged to other serotypes.
Antimicrobial susceptibility results
Antimicrobial susceptibility testing by disc method revealed that 28 isolates were resistant to NA, whereas 12
isolates were intermediate susceptible to NA (Table 2) . exhibited a high level of resistance to both CIP (12 μg/ml) and NOR (48 μg/ml). The remaining isolates for CIP and NOR were 0.047~0.25 μg/ml and 0.25~2 μg/ml, respectively. Among the 40 isolates, 19 (47.5%) showed increased MIC (≥ 0.125 μg/ml) for CIP. (MIC >256 μg/ml) ( Table 3 
Detection of plasmid-mediated quinolone resistance (PMQR) genes
The PMQR genes were detected in 14 (35%) of the 40
Salmonella isolates (Table 3 ). The most commonly observed qnr-positive serotypes were Montevideo (N=11), followed by Othmarschen (N=2), and Typhimurium (N=1). The qnrB gene was detected in 13 of the 14 qnr-positive isolates and the MICs of NA ranged from 4 μg/ml to 16 μg/ml. The qnrA gene and aac(6')-Ib-cr were found in only 1 strain and MICs of NA, CIP, and NOR were 8 μg/ml, 0.25 μg/ml, and 2 μg/ml, respectively. The qnrS and qepA genes were not detected in any of the Salmonella strains in this study.
DISCUSSION
In the current study, we investigated mechanisms of Consistent with previous reports, we found that the main mechanism of NA resistance was single point mutations in the QRDR region of the gyrA gene at codons 83 or 87. In this study, Ser83 changed at Tyr, Leu, and Phe and Asp87 changed at Asn, Gly, and Tyr. These results were same with the substitution which had been reported as the most frequent substitution in GyrA of Salmonella (5, 14, 16, 18, 19) . A previous study by Fabrega et al. (14) suggested that the position of the mutations in the gyrA gene and the substituting amino acid can be depended on the serovar analysis. In this study, there was the difference in several papers (15, 17) and this reason is considered to be the origin and the serotypes. The occasion mutation of ParC had been reported. Also, the substitution from Thr57 to Ser had been reported as the occasion mutation in ParC (14) . In this study, three isolates (two of Haardt, one of Bovismorbificans)
showed same substitution form with the substitution from Thr57 to Ser. In Korea, the research of substitution form had been reported by Jeong et al. (19) and Kim et al. (20) and it showed that the substitution from Thr57 to Ser happens occasionally. In Salmonella, given the fact that a 
